RGEN

NASDAQStock

Repligen Corporation

$114.62-4.78 (-4.01%)

52-Week Range

$108.89

$172.26

Key Stats

Market Cap

6.5B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Volume

910.9K

Avg Volume

905.3K

Performance

-18.39%

-29.16%

+0.02%

YTD

-30.78%

-20.13%

-34.71%

-44.24%

Price Chart

ETF Exposure

RGEN is held by 159 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	114	$14K	$733.2M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	351	$43K	$1.69B	0.20%
DFUV	Dimensional - US Marketwide Value ETF	0.00%	961	$117K	$13.50B	0.21%
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	2	$225	$9.0M	0.30%
IRTR	iShares LifePath Retirement ETF	0.00%	10	$1K	$52.3M	0.08%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	15	$2K	$61.4M	0.09%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.00%	17	$2K	$163.7M	0.12%
CHEP	AGFiQ U.S. Market Neutral Value Fund	0.00%	-26	$0	$747K	1.42%
FTLS	First Trust Long/Short Equity ETF	0.00%	-29,399	$0	$2.16B	1.38%

PreviousPage 4 of 4

About RGEN ETF Exposure

Repligen Corporation (RGEN) is held by 159 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 6.5B, RGEN is a widely held institutional stock. The stock currently trades at $114.62. Investors can gain exposure to RGEN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RGEN, sorted by portfolio weight.